The effect of the N compound in the treatment of knee pai

Phase 2

Recruiting

• Conditions: Rheumatoid Arthritis.; Rheumatoid arthritis, unspecified; M06.9

• Registration Number: IRCT20210413050959N2
• Lead Sponsor: Rafsanjan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 November 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

45-70 years old
Confirmation of the disease by a rheumatologist according to the criteria of the American College of Rheumatology

Exclusion Criteria

Inflammatory disease
Disease the heart
Liver disease
Kidney disease
Allergy to herbal medicines
Smoking
Drug use
Painkillers uses
supplements and medicines uses
Daily painkillers uses

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Knee pain. Timepoint: before intervention and after intervention. Method of measurement: Visual Analogue Scale (VAS) and WOMAC (Western Ontario and Mc Master) questionnaire.;The joints morning stiffness. Timepoint: before intervention and after intervention. Method of measurement: Visual Analogue Scale (VAS) and WOMAC (Western Ontario and Mc Master) questionnaire.;The Knee range of motion. Timepoint: before intervention and after intervention. Method of measurement: Visual Analogue Scale (VAS) and WOMAC (Western Ontario and Mc Master) questionnaire.;The Knee function. Timepoint: before intervention and after intervention. Method of measurement: Visual Analogue Scale (VAS) and WOMAC (Western Ontario and Mc Master) questionnaire.